Seven Eight Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Seven Eight Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,231	Closed	-$656K	–	695
2023 Q1	$656K	Buy	+27,231	New	+$342K	0.14%	202

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Seven Eight Capital's PRVB Position: Q2 2023 in Review

Seven Eight Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 27,231 shares — an estimated $656K sold.

Seven Eight Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $656K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Seven Eight Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Seven Eight Capital sold 27,231 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $656K.
Seven Eight Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Seven Eight Capital's Provention Bio, Inc. Common Stock position peaked at $656K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.